HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chunmei Li Selected Research

LPM4870108

1/2022The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats.
6/2021Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chunmei Li Research Topics

Disease

38Neoplasms (Cancer)
09/2022 - 09/2005
15Body Weight (Weight, Body)
01/2022 - 06/2009
13Inflammation (Inflammations)
06/2022 - 09/2011
8Infections
05/2022 - 03/2009
7Pain (Aches)
01/2022 - 07/2007
7Necrosis
02/2020 - 04/2010
7Myocardial Infarction
01/2017 - 02/2010
6Neuralgia (Stump Neuralgia)
10/2021 - 07/2007
6Ciliopathies
12/2018 - 03/2009
5Fibrosis (Cirrhosis)
12/2018 - 05/2012
5Infarction (Infarctions)
01/2017 - 06/2011
5Meckel syndrome type 1
03/2016 - 03/2009
5Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2013 - 07/2005
5HIV Infections (HIV Infection)
03/2012 - 08/2008
5Syphilis
03/2012 - 03/2009
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2009
4COVID-19
01/2022 - 08/2020
4Carcinogenesis
01/2022 - 12/2015
4Autoimmune Diseases (Autoimmune Disease)
12/2021 - 04/2003
4Colonic Neoplasms (Colon Cancer)
11/2017 - 12/2013
4Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
12/2016 - 05/2007
4Tuberculosis (Tuberculoses)
01/2014 - 01/2011
4Myocardial Ischemia (Ischemic Heart Diseases)
05/2012 - 02/2010
3Colitis
05/2022 - 01/2021
3Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2020
3Ganglion Cysts (Ganglion)
01/2022 - 11/2010
3Obesity
01/2022 - 10/2018
3Cognitive Dysfunction
01/2022 - 03/2012
3Virus Diseases (Viral Diseases)
12/2021 - 03/2016
3Sepsis (Septicemia)
09/2021 - 03/2008
3Breast Neoplasms (Breast Cancer)
01/2021 - 08/2008
3Prostatic Neoplasms (Prostate Cancer)
10/2020 - 01/2016
3Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2017
3Ischemia
06/2014 - 02/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2022 - 01/2022
2Bites and Stings (Sting)
12/2021 - 10/2021
2Hyperalgesia
10/2021 - 01/2019
2Rheumatoid Arthritis
04/2021 - 03/2018
2Epilepsy (Aura)
01/2021 - 01/2019
2Weight Gain
01/2021 - 06/2017
2Hypertension (High Blood Pressure)
01/2021 - 06/2002

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
05/2022 - 10/2005
14Pharmaceutical PreparationsIBA
12/2021 - 01/2006
12Biomarkers (Surrogate Marker)IBA
05/2022 - 02/2015
8AntioxidantsIBA
04/2022 - 10/2009
7Glucose (Dextrose)FDA LinkGeneric
09/2020 - 06/2002
7AmidesIBA
02/2020 - 07/2015
7Protons (Proton)IBA
02/2020 - 07/2015
6EnzymesIBA
01/2021 - 02/2010
5Long Noncoding RNAIBA
08/2022 - 01/2018
5CytokinesIBA
04/2022 - 05/2013
5DNA (Deoxyribonucleic Acid)IBA
10/2021 - 12/2008
4Biological ProductsIBA
04/2022 - 08/2010
4Therapeutic UsesIBA
12/2021 - 06/2011
4Interleukin-6 (Interleukin 6)IBA
04/2021 - 08/2019
4Glyphosate (Roundup)IBA
06/2020 - 12/2018
4MicroRNAs (MicroRNA)IBA
04/2020 - 08/2014
4Phosphotransferases (Kinase)IBA
02/2020 - 01/2018
3PolyphenolsIBA
06/2022 - 10/2017
3Particulate MatterIBA
04/2022 - 11/2019
3Malondialdehyde (Propanedial)IBA
01/2022 - 02/2010
3Retinaldehyde (Retinal)IBA
01/2022 - 11/2010
3Glutathione PeroxidaseIBA
01/2022 - 02/2010
3astaxanthine (astaxanthin)IBA
09/2021 - 09/2020
3Messenger RNA (mRNA)IBA
01/2021 - 01/2018
3RNA (Ribonucleic Acid)IBA
01/2021 - 07/2005
3Peptide Hydrolases (Proteases)FDA Link
11/2020 - 01/2006
3TanninsIBA
08/2020 - 02/2018
3GoldIBA
04/2020 - 03/2014
3APTIBA
01/2020 - 07/2015
3Troponin T (Troponin T1)IBA
01/2020 - 02/2010
3Caspase 3 (Caspase-3)IBA
08/2019 - 12/2010
3Triglycerides (Triacylglycerol)IBA
10/2018 - 08/2005
3Indicators and Reagents (Reagents)IBA
02/2017 - 05/2013
3Hydroxyproline (4 Hydroxyproline)IBA
01/2017 - 05/2012
3Cyclin-Dependent Kinase Inhibitor p16IBA
08/2013 - 09/2005
3akebia saponin DIBA
05/2012 - 02/2010
3Polysaccharides (Glycans)IBA
03/2012 - 08/2005
3Peptides (Polypeptides)IBA
03/2012 - 07/2007
2Antiviral Agents (Antivirals)IBA
09/2022 - 01/2021
2LipopolysaccharidesIBA
06/2022 - 04/2022
2Dextran SulfateIBA
05/2022 - 01/2022
2InflammasomesIBA
05/2022 - 01/2022
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 12/2013
2Analgesics (Analgesic Drugs)IBA
01/2022 - 01/2019
2LPM4870108IBA
01/2022 - 06/2021
2InterferonsIBA
12/2021 - 10/2021
2Monoclonal AntibodiesIBA
12/2021 - 01/2012
2Formaldehyde (Formol)FDA Link
10/2021 - 01/2019
2PCC-0105002IBA
10/2021 - 08/2020
2Interferon Type IIBA
03/2021 - 01/2019
2Testosterone (Sustanon)FDA Link
01/2021 - 11/2013
2AntibodiesIBA
01/2021 - 02/2010
2Nucleic AcidsIBA
01/2021 - 08/2013

Therapy/Procedure

17Therapeutics
04/2022 - 03/2008
4Drug Therapy (Chemotherapy)
09/2022 - 01/2020
4Condoms (Condom)
03/2012 - 03/2009
3Aftercare (After-Treatment)
04/2022 - 01/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2020 - 06/2009
2Adjuvant Chemotherapy
09/2022 - 01/2021